These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

343 related items for PubMed ID: 20029537

  • 1. Role of insulin-like growth factor 1 receptor and c-Src in endothelin-1- and angiotensin II-induced PKB phosphorylation, and hypertrophic and proliferative responses in vascular smooth muscle cells.
    Bouallegue A, Vardatsikos G, Srivastava AK.
    Can J Physiol Pharmacol; 2009 Dec; 87(12):1009-18. PubMed ID: 20029537
    [Abstract] [Full Text] [Related]

  • 2. Activation of insulin-like growth factor type-1 receptor is required for H2O2-induced PKB phosphorylation in vascular smooth muscle cells.
    Azar ZM, Mehdi MZ, Srivastava AK.
    Can J Physiol Pharmacol; 2006 Jul; 84(7):777-86. PubMed ID: 16998541
    [Abstract] [Full Text] [Related]

  • 3. Contribution of epidermal growth factor receptor transactivation in angiotensin II-induced enhanced expression of Gi protein and proliferation in A10 vascular smooth muscle cells.
    Gomez Sandoval YH, Lévesque LO, Anand-Srivastava MB.
    Can J Physiol Pharmacol; 2009 Dec; 87(12):1037-45. PubMed ID: 20029540
    [Abstract] [Full Text] [Related]

  • 4. Reactive oxygen species mediate Endothelin-1-induced activation of ERK1/2, PKB, and Pyk2 signaling, as well as protein synthesis, in vascular smooth muscle cells.
    Daou GB, Srivastava AK.
    Free Radic Biol Med; 2004 Jul 15; 37(2):208-15. PubMed ID: 15203192
    [Abstract] [Full Text] [Related]

  • 5. IGF-1 receptor transactivation mediates Src-dependent cortactin phosphorylation in response to angiotensin II.
    Zahradka P, Storie B, Wright B.
    Can J Physiol Pharmacol; 2009 Oct 15; 87(10):805-12. PubMed ID: 19898563
    [Abstract] [Full Text] [Related]

  • 6. Insulin-like growth factor type-1 receptor transactivation in vasoactive peptide and oxidant-induced signaling pathways in vascular smooth muscle cells.
    Azar ZM, Mehdi MZ, Srivastava AK.
    Can J Physiol Pharmacol; 2007 Jan 15; 85(1):105-11. PubMed ID: 17487250
    [Abstract] [Full Text] [Related]

  • 7. Redox-dependent MAP kinase signaling by Ang II in vascular smooth muscle cells: role of receptor tyrosine kinase transactivation.
    Touyz RM, Cruzado M, Tabet F, Yao G, Salomon S, Schiffrin EL.
    Can J Physiol Pharmacol; 2003 Feb 15; 81(2):159-67. PubMed ID: 12710530
    [Abstract] [Full Text] [Related]

  • 8. Enhanced levels of endogenous endothelin-1 contribute to the over expression of Giα protein in vascular smooth muscle cells from SHR: Role of growth factor receptor activation.
    Gomez Sandoval YH, Anand-Srivastava MB.
    Cell Signal; 2011 Feb 15; 23(2):354-62. PubMed ID: 20959139
    [Abstract] [Full Text] [Related]

  • 9. Involvement of insulin-like growth factor 1 receptor transactivation in endothelin-1-induced signaling in vascular smooth muscle cells.
    Bouallegue A, Vardatsikos G, Srivastava AK.
    Can J Physiol Pharmacol; 2010 May 15; 88(5):501-9. PubMed ID: 20555420
    [Abstract] [Full Text] [Related]

  • 10. Role of growth factor receptor transactivation in high glucose-induced increased levels of Gq/11alpha and signaling in vascular smooth muscle cells.
    Descorbeth M, Anand-Srivastava MB.
    J Mol Cell Cardiol; 2010 Aug 15; 49(2):221-33. PubMed ID: 20036247
    [Abstract] [Full Text] [Related]

  • 11. Insulin-like growth factor-I (IGF-I) induces epidermal growth factor receptor transactivation and cell proliferation through reactive oxygen species.
    Meng D, Shi X, Jiang BH, Fang J.
    Free Radic Biol Med; 2007 Jun 01; 42(11):1651-60. PubMed ID: 17462533
    [Abstract] [Full Text] [Related]

  • 12. Aldosterone and angiotensin II synergistically stimulate migration in vascular smooth muscle cells through c-Src-regulated redox-sensitive RhoA pathways.
    Montezano AC, Callera GE, Yogi A, He Y, Tostes RC, He G, Schiffrin EL, Touyz RM.
    Arterioscler Thromb Vasc Biol; 2008 Aug 01; 28(8):1511-8. PubMed ID: 18467645
    [Abstract] [Full Text] [Related]

  • 13. Insulin-like growth-factor-1-induced PKB signaling and Egr-1 expression is inhibited by curcumin in A-10 vascular smooth muscle cells.
    Youreva V, Kapakos G, Srivastava AK.
    Can J Physiol Pharmacol; 2013 Mar 01; 91(3):241-7. PubMed ID: 23537438
    [Abstract] [Full Text] [Related]

  • 14. Plasminogen activator inhibitor type-1 gene expression and induced migration in TGF-beta1-stimulated smooth muscle cells is pp60(c-src)/MEK-dependent.
    Samarakoon R, Higgins CE, Higgins SP, Kutz SM, Higgins PJ.
    J Cell Physiol; 2005 Jul 01; 204(1):236-46. PubMed ID: 15622520
    [Abstract] [Full Text] [Related]

  • 15. Vascular smooth muscle cell NAD(P)H oxidase activity during the development of hypertension: Effect of angiotensin II and role of insulinlike growth factor-1 receptor transactivation.
    Cruzado MC, Risler NR, Miatello RM, Yao G, Schiffrin EL, Touyz RM.
    Am J Hypertens; 2005 Jan 01; 18(1):81-7. PubMed ID: 15691621
    [Abstract] [Full Text] [Related]

  • 16. Attenuation of endothelin-1-induced PKB and ERK1/2 signaling, as well as Egr-1 expression, by curcumin in A-10 vascular smooth muscle cells.
    Kapakos G, Youreva V, Srivastava AK.
    Can J Physiol Pharmacol; 2012 Sep 01; 90(9):1277-85. PubMed ID: 22913328
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Transactivation of epidermal growth factor receptor by enhanced levels of endogenous angiotensin II contributes to the overexpression of Giα proteins in vascular smooth muscle cells from SHR.
    Sandoval YH, Li Y, Anand-Srivastava MB.
    Cell Signal; 2011 Nov 01; 23(11):1716-26. PubMed ID: 21712088
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.